GleamWall
中文EN

WGS GeneDx Holdings Corp.

Services-Health Services · Nasdaq · SEC CIK 1818331 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.6%
TTM net income YoY-5,431.2%
TTM EPS YoY-3,518.2%
Revenue 3-yr CAGR30.7%
Net income 3-yr CAGR—

Margins

Gross margin68.7%
Operating margin-21.6%
Net margin-24.1%
FCF margin-22.0%
EBITDA margin-19.0%

Returns

ROE-41.4%
ROA-21.8%
ROIC (approx.)-29.0%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets53.5%
Debt / equity0.60x
Current ratio4.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio-7.1%
Payout ratio—
Capex / revenue5.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$123.10M$114.44M$102.25M$120.99M$116.74M$102.69M$87.11M$95.64M
Cost of revenue$37.04M$36.20M$34.04M$36.72M$32.22M$31.79M$28.64M$29.43M
Gross profit$86.06M$78.24M$68.21M$84.27M$84.53M$70.90M$58.48M$66.20M
R&D expense$17.37M$19.66M$19.80M$24.54M$19.83M$15.08M$12.58M$11.59M
SG&A expense$79.12M$76.04M$74.59M$46.83M$67.95M$46.86M$50.45M$28.14M
Operating income-$10.43M-$17.45M-$57.47M-$14.23M-$3.25M$8.96M-$4.55M$8.81M
Pretax income-$12.30M-$18.26M-$62.42M-$18.23M-$7.39M$10.56M-$6.08M$5.41M
Income tax$26,000-$518,000$897,000-$564,000$247,000-$246,000$447,000-$24,000
Net income-$12.33M-$17.74M-$63.32M-$17.67M-$7.63M$10.81M-$6.53M$5.44M
EBITDA-$7.13M-$14.36M-$54.77M-$11.44M-$851,000$11.26M-$2.35M$10.83M
EPS (basic)-0.41-0.60-2.16—-0.270.38-0.23—
EPS (diluted)-0.41-0.60-2.16—-0.270.36-0.23—
Weighted avg. shares (diluted)29.88M29.71M29.34M—28.80M29.75M28.15M—
Balance sheet
Cash & equivalents$96.14M$60.32M$93.92M$105.00M$96.96M$75.11M$100.69M$86.20M
Short-term investments$73.98M$72.23M$76.76M$66.28M$59.11M$60.44M$59.46M$55.97M
Receivables$92.13M$83.61M$76.93M$74.37M$60.94M$48.03M$45.98M$37.63M
Inventory$21.70M$17.82M$12.24M$13.95M$10.57M$11.93M$12.66M$10.65M
Current assets$296.89M$246.36M$270.63M$268.29M$237.58M$204.84M$225.82M$197.97M
PP&E, net$53.53M$54.32M$50.12M$45.69M$42.42M$40.12M$36.38M$32.89M
Goodwill$1.64M$1.64M$1.64M$13.52M$12.80M$12.93M—$0
Intangibles$137.73M$141.35M$144.97M$168.48M$172.59M$176.69M$155.09M$158.60M
Total assets$526.48M$481.49M$506.30M$523.71M$493.90M$463.86M$446.43M$419.38M
Current liabilities$71.40M$74.63M$87.64M$108.91M$87.62M$71.41M$69.54M$54.82M
Short-term debt$0$0$0$4.54M$1.23M$1.22M$1.22M$1.21M
Long-term debt$146.23M$96.84M$96.73M$48.18M$51.58M$51.68M$51.79M$51.91M
Total debt$146.23M$96.84M$96.73M$52.72M$52.81M$52.91M$53.01M$53.12M
Total liabilities$281.80M$237.26M$252.18M$215.53M$201.64M$186.73M$189.03M$174.13M
Shareholders' equity$244.69M$244.22M$254.12M$308.18M$292.26M$277.13M$257.40M$245.25M
Net debt$50.09M$36.52M$2.81M-$52.28M-$44.15M-$22.20M-$47.68M-$33.08M
Shares outstanding29.95M29.80M29.67M29.25M28.89M28.71M28.53M28.02M
Cash flow statement
Operating cash flow-$10.60M-$28.98M-$32.41M-$3.09M$15.77M$10.42M$10.18M-$3.18M
Capital expenditure$5.22M$10.11M$6.45M$4.35M$6.17M$2.37M$6.13M$3.05M
Free cash flow-$15.82M-$39.09M-$38.86M-$7.44M$9.60M$8.05M$4.05M-$6.23M
Investing cash flow-$7.42M-$5.63M-$17.25M-$11.07M-$4.69M-$36.35M-$9.41M-$519,000
Financing cash flow$53.84M$1.00M$38.59M$23.19M$10.77M$346,000$13.72M$31.02M
Depreciation & amortization$3.30M$3.10M$2.70M$2.80M$2.40M$2.30M$2.20M$2.02M
Stock-based compensation$8.25M$6.34M$9.00M$9.78M$10.59M$7.81M$3.98M$2.85M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.